Given that (1) GPX4 is responsible for ferroptotic cell death induced by lipid peroxidation signaling and (2) knockdown of GPX4 expression using siRNA reagents is sufficient to induce ferroptosis (Yang et al., 2014), GPX4 inhibitors maybe potential candidates for cancer therapy. This evidence concerns the gene GPX4 and cancer.